Ramifications of screening for breast cancer: Overdiagnosis in the Malmö trial was considerably underestimatedBMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7543.727-a (Published 23 March 2006) Cite this as: BMJ 2006;332:727
- Peter C Gøtzsche, director ([email protected])
- Nordic Cochrane Centre, Rigshospitalet, DK-2100 Copenhagen Ø, Denmark
EDITOR—Updated results from the Malmö mammography screening trial have suggested that screening caused an over-diagnosis of breast cancer of 10% in women aged 55-69 years at randomisation.1 The authors noted that evidence from randomised trials on the level of overdiagnosis was lacking. This is not correct. On the basis of data from the Malmö trial,2 and the two trials from Canada,3 we have previously estimated a level of overdiagnosis of 30% (mean follow-up 8.8 years and 7 years, respectively)4 and have also suggested an over-diagnosis of 33% in …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial